As proposed [17], a decrease in anti-tumor T-cells in blood is compatible with trafficking of those cells to the tumor, a notion supported by evidence in this case, as CD8+ cells increased 26-fold in the tumor. The gene discussed is CD8A; the disease is neoplasm.